Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canakinumab for the Treatment of Postprandial Hypoglycemia - CanpHy Study

NCT05401578 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT05401578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05401578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canakinumab for the Treatment of Postprandial Hypoglycemia - CanpHy Study
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Phase 3
Overall status
Recruiting
Start date
April 17, 2023
Completion date
May 31, 2026
Enrollment
56 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

postprandial hypoglycemia